Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Equity Ratio (2020 - 2025)

Biofrontera has reported Equity Ratio over the past 6 years, most recently at 0.37 for Q4 2025.

  • For Q4 2025, Equity Ratio rose 82.92% year-over-year to 0.37; the TTM value through Dec 2025 reached 0.37, up 82.92%, while the annual FY2025 figure was 0.37, 82.92% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.37 at Biofrontera, up from 0.17 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.51 in Q2 2024 and troughed at 1.13 in Q3 2021.
  • A 5-year average of 0.12 and a median of 0.21 in 2021 define the central range for Equity Ratio.
  • Biggest five-year swings in Equity Ratio: soared 881.26% in 2024 and later tumbled 156.06% in 2025.
  • Year by year, Equity Ratio stood at 0.21 in 2021, then surged by 120.27% to 0.47 in 2022, then crashed by 63.43% to 0.17 in 2023, then increased by 16.89% to 0.2 in 2024, then soared by 82.92% to 0.37 in 2025.
  • Business Quant data shows Equity Ratio for BFRI at 0.37 in Q4 2025, 0.17 in Q3 2025, and 0.23 in Q2 2025.